Research progress of Mingmu-11 and its active ingredients for the treatment of diabetic macular edema
Diabetic macular edema(DME)is one of the vision-threatening ocular complications of diabetes and is an important cause of blindness in adults. At present, there are 141 million diabetics in China. With the increase of the number of diabetics, the incidence of DME is also increasing year by year. Mod...
Main Authors: | Lin-Lin Ran, Riguga Su, Wen-Lin Chen, Qin Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2022-12-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2022/12/202212010.pdf |
Similar Items
-
Mongolian medicine Mingmu-11 Pills combined with Conbercept in the treatment of wet age-related macular degeneration
by: Su Riguga, et al.
Published: (2024-05-01) -
Yishen Yanggan Mingmu formula combined with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration
by: Jian Gao, et al.
Published: (2023-08-01) -
Anatomical and Functional Effects of Oral Administration of Curcuma Longa and Boswellia Serrata Combination in Patients with Treatment-Naïve Diabetic Macular Edema
by: Olimpia Guarino, et al.
Published: (2022-07-01) -
Topical interferon therapy in uveitic macular edema
by: Ankush Kawali, et al.
Published: (2022-01-01) -
Triamcinolona subtenoniana en el edema macular diabético Subtenon triamcinolone in the diabetic macular edema
by: Eddy Mesa Hernández, et al.
Published: (2009-12-01)